Cardinal Health Issues Correction for Infusion Sets
Cardinal Health is notifying customers to discard recalled BD Alaris infusion sets found in its Presource kits.
Updated on Oct. 20, 2026 in Nursing Jobs
Live Poll
Do you trust local healthcare facilities to quickly identify and remove recalled medical equipment?
On September 24, 2026, Cardinal Health issued a notification regarding Presource kits that contain recalled BD Alaris infusion sets. These medical device sets are linked to potential pump malfunctions.
Why it matters
Malfunctioning infusion sets can cause unpredictable pump behavior, including over-infusion or failure to infuse, which creates significant health risks for patients. Ensuring these specific sets are removed from use is essential to preventing potential adverse events.
As of August 19, 2026, no serious injuries or deaths have been reported despite the potential for pump failure. For assistance, facilities may contact the Cardinal Health customer service line at (800) 292-9332.
The players
Cardinal Health
Cardinal Health is a global integrated healthcare services and products company that provides customized solutions for hospitals, health systems, and pharmacies.
BD
BD, or Becton, Dickinson and Company, is a multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents.
FDA
The Food and Drug Administration is the federal agency responsible for protecting public health by ensuring the safety and efficacy of medical devices.
The details
The recall impacts BD and CareFusion BD Alaris Pump Infusion Sets included within Cardinal Health Presource kits. Clinicians are instructed to immediately quarantine affected kits and discard the specific recalled sets to mitigate the risk of unpredictable infusion performance.
Timeline
August 19, 2026: Date of status report with no reported serious injuries.
September 24, 2026: Cardinal Health sent notification letter to affected customers.
October 20, 2026: FDA issued public early alert.
Market Landscape
This correction follows established FDA safety protocols for managing and communicating risks associated with distributed medical hardware. It highlights the complex supply chain challenges inherent in bundling third-party medical devices into integrated kits.
Healthcare providers must immediately audit their inventory to quarantine Presource kits and remove any recalled BD Alaris infusion sets to ensure patient safety. Failure to follow these removal instructions could lead to dangerous variations in patient medication dosage.
The takeaway
Clinicians should remain vigilant about checking the compatibility of pre-packaged kits against active recall notices issued by distributors. Proper identification and disposal of faulty components remain the most effective way to prevent medical equipment failure in clinical settings.
Further reading
For more information on medical staffing and equipment safety, visit Nursing Jobs.
Source note: This article includes information reported by U.S. Food and Drug Administration.
Live Poll
Do you trust local healthcare facilities to quickly identify and remove recalled medical equipment?
